- Home
- SISI vs IRIX Comparison
SISI vs IRIX Comparison
Compare SISI & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SISI
- IRIX
- Stock Information
- Founded
- SISI 1997
- IRIX 1989
- Country
- SISI China
- IRIX United States
- Employees
- SISI N/A
- IRIX N/A
- Industry
- SISI Medicinal Chemicals and Botanical Products
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SISI Health Care
- IRIX Health Care
- Exchange
- SISI Nasdaq
- IRIX Nasdaq
- Market Cap
- SISI 17.9M
- IRIX 20.6M
- IPO Year
- SISI 2016
- IRIX 1996
- Fundamental
- Price
- SISI $0.89
- IRIX $1.03
- Analyst Decision
- SISI
- IRIX Hold
- Analyst Count
- SISI 0
- IRIX 1
- Target Price
- SISI N/A
- IRIX $2.00
- AVG Volume (30 Days)
- SISI 128.8K
- IRIX 142.5K
- Earning Date
- SISI 05-14-2025
- IRIX 03-27-2025
- Dividend Yield
- SISI N/A
- IRIX N/A
- EPS Growth
- SISI N/A
- IRIX N/A
- EPS
- SISI N/A
- IRIX N/A
- Revenue
- SISI $11,072,553.00
- IRIX $48,669,000.00
- Revenue This Year
- SISI N/A
- IRIX N/A
- Revenue Next Year
- SISI N/A
- IRIX $5.44
- P/E Ratio
- SISI N/A
- IRIX N/A
- Revenue Growth
- SISI 145.88
- IRIX N/A
- 52 Week Low
- SISI $0.73
- IRIX $0.78
- 52 Week High
- SISI $117.65
- IRIX $3.65
- Technical
- Relative Strength Index (RSI)
- SISI 44.31
- IRIX 45.12
- Support Level
- SISI $0.85
- IRIX $0.78
- Resistance Level
- SISI $1.27
- IRIX $1.07
- Average True Range (ATR)
- SISI 0.16
- IRIX 0.12
- MACD
- SISI 0.02
- IRIX 0.02
- Stochastic Oscillator
- SISI 30.64
- IRIX 54.35
About SISI Shineco Inc.
Shineco Inc aims to care for a healthy life and improve the quality of life by providing safe, efficient, and high-quality health products and services to society. The company has researched and developed various vitro diagnostic reagents and related medical devices to date, and it also produces and sells healthy and nutritious food.
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.